Concepedia

Author

Françoise Tonner

Pierre Fabre (France)ORCID

Also Known As

F. Tonner, Françoise Tonner

13

Publications

290

Citations

8

H-Index

14

Concepts

All Affiliations

Pierre Fabre (France)UCB Pharma (Belgium)Servier (France)Columbia University Irving Medical CenterUCB Pharma (United States)
FT

About

Françoise Tonner is an author at Pierre Fabre (France) specializing in medicine, neuropharmacology, and psychopharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

98

2

Social Sciences

2

2

49

3

Neurology

2

2

49

4

Pharmacology

2

2

49

5

Neuroscience

1

1

16

Françoise Tonner

×

7

Publications

178

Citations

7

H-Index

YearCitations

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: Open‐label, noncomparative, multicenter, long‐term follow‐up study

Norman Delanty, John J. Jones, Françoise Tonner

Epilepsia

2011

52

Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia

István Bitter, Jeffrey A. Lieberman, Florence Gaudoux,

Neuropsychopharmacology

2019

33

Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients

Kyoung Heo, Byung In Lee, Sang Do Yi,

Seizure

2007

27

Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study

Patrick Kwan, Shih Hui Lim, Yotin Chinvarun,

Epilepsy & Behavior

2010

22

Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO

Mark Slifstein, Anissa Abi‐Dargham, Ragy R. Girgis,

Psychopharmacology

2019

16

Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis

Matthew E. Hudgens‐Haney, Brett A. Clementz, Elena I. Ivleva,

Schizophrenia Bulletin

2020

16

Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo‐controlled, double‐blind, noninferiority study

Ulrike Blume‐Peytavi, Zahida Issiakhem, S. Gautier,

Journal of Cosmetic Dermatology

2018

12

Page 1